Search by Drug Name or NDC

    NDC 50268-0721-15 Ranitidine 150 mg/1 Details

    Ranitidine 150 mg/1

    Ranitidine is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by AvPAK. The primary component is RANITIDINE HYDROCHLORIDE.

    Product Information

    NDC 50268-0721
    Product ID 50268-721_89175238-3add-22cd-e053-2a95a90ad3f0
    Associated GPIs 49200020100305
    GCN Sequence Number 011673
    GCN Sequence Number Description ranitidine HCl TABLET 150 MG ORAL
    HIC3 Z2D
    HIC3 Description HISTAMINE H2-RECEPTOR INHIBITORS
    GCN 10200
    HICL Sequence Number 004520
    HICL Sequence Number Description RANITIDINE HCL
    Brand/Generic Generic
    Proprietary Name Ranitidine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Ranitidine
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name RANITIDINE HYDROCHLORIDE
    Labeler Name AvPAK
    Pharmaceutical Class Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA210243
    Listing Certified Through 2022-12-31

    Package

    NDC 50268-0721-15 (50268072115)

    NDC Package Code 50268-721-15
    Billing NDC 50268072115
    Package 50 BLISTER PACK in 1 BOX (50268-721-15) / 1 TABLET in 1 BLISTER PACK (50268-721-11)
    Marketing Start Date 2019-05-17
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 891713fa-e572-371c-e053-2995a90ae88d Details

    Revised: 5/2019